Page last updated at 00:00 GMT, Tuesday, 26 January 2010

Hepatitis fight aided by liver cells advance

Liver cells
Hundreds of millions of people worldwide are thought to be infected with hepatitis C

Scientists looking for a treatment for a dangerous liver virus have found new ways to study it in the laboratory.

For the first time, a US team managed to watch the progress of a rare strain of hepatitis C among liver cells kept alive in a lab dish.

In the journal, the Proceedings of the National Academy of Sciences, they say it could lead to easier drug testing.

However, a UK expert said the method needed to work with more common hepatitis strains.

Hundreds of millions of people worldwide are thought to be infected with hepatitis C.

For most, it is an asymptomatic infection, but a small percentage, often many years later, develop liver cancer or failure.

This is a tool which can be used to study hepatitis C in more detail, and with greater accuracy, than existing culture systems
Professor William Rosenberg, UCL

One of the obstacles to the disease's study is that while many types of human cells can be grown successfully in the laboratory, liver cells have always been problematic.

After a very short while in a lab dish, the cells normally change or "differentiate" into forms which no longer behave in the same way.

The researchers from Massachusetts Institute of Technology (MIT) were able to extend their useful life by weeks by using a lab dish with a tiny pattern on its base.

This directed the cells to exactly the right place, and allowed other types of cells, called fibroblasts, to align with the liver cells.

This was important because fibroblasts are known to support the growth of liver cells.

Drug testing

Professor Sangeeta Bhatia, who led the research alongside scientists from Rockefeller University in New York, said: "If you just put cells on a surface in an unorganised way, they lose their function very quickly - if you specify which cells sit next to each other, you can extend the lifetime of the cells and help them maintain their function."

In addition, the team managed to infect their cells with a strain of hepatitis C, opening the opportunity for potential drugs to be tested over a two or three-week period.

William Rosenberg, a professor of hepatology at University College London, said that the research represented a "significant advance".

He added: "This is a tool which can be used to study hepatitis C in more detail, and with greater accuracy, than existing culture systems."

However, the cells were infected with a strain of hepatitis C responsible for a very small number of very severe cases of the illness, and Professor Roger Williams, also from University College London.

He said that the success would have to be repeated using more common strains.

"What they have managed to do is interesting, but this is a very unusual strain, and patients with this form of 'fulminant hepatitis' are very different to those with other strains of the virus."



Print Sponsor


SEE ALSO
Primary liver cancers 'soaring'
19 Aug 09 |  Health
Drug could reverse liver disease
01 Jun 09 |  Tyne
Tainted blood victims left angry
20 May 09 |  Health

RELATED INTERNET LINKS
The BBC is not responsible for the content of external internet sites

FROM OTHER NEWS SITES
Telegraph Stem cell research could 'weed' out cancer - 9 hrs ago
Times Online Meet Marvin, the robot that can plug itself in - 18 hrs ago
Reuters UK Scientists find quicker way to study cancer drivers - 20 hrs ago
Guardian.co.uk Mary English obituary - 23 hrs ago



FEATURES, VIEWS, ANALYSIS
Has China's housing bubble burst?
How the world's oldest clove tree defied an empire
Why Royal Ballet principal Sergei Polunin quit

BBC navigation

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.

Americas Africa Europe Middle East South Asia Asia Pacific